Cryopreserved autologous marrow infusion following high dose cancer chemotherapy

Jeffrey S. Tobias, Roy S. Weiner, C. Thomas Griffiths, Carol M Richman, Leroy M. Parker, Ronald A. Yankee

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Seventeen patients with advanced malignancies received escalating doses of chemotherapy with adriamycin and cyclophosphamide. Sixty-five per cent of the courses produced circulating granulocyte counts of 500 cells/mm3 or less. Febrile episodes occurred in only 15% of courses and were seen only with doses of chemotherapy that produced granulocyte nadirs of less than 200 cells/mm3. There were no episodes of septicaemia. Ten of the 17 patients received an intensive dose followed by reinfusion of cryopreserved, autologous bone marrow. In 5 of these patients, recovery to 500 granulocytes/mm3 was more rapid following the intensive, marrow-supported course by comparison with the prior, less intensive, unsupported course. We conclude that higher doses of adriamycin and cyclophosphamide than are conventionally used can be given without serious toxicity. Autologous bone marrow reinfusion may have a role in reducing the period of drug-induced granulocytopenia, but effective storage and recovery of human bone marrow remains a major problem.

Original languageEnglish (US)
Pages (from-to)269-277
Number of pages9
JournalEuropean Journal of Cancer (1965)
Volume13
Issue number3
DOIs
StatePublished - 1977
Externally publishedYes

Fingerprint

Bone Marrow
Granulocytes
Drug Therapy
Doxorubicin
Cyclophosphamide
Neoplasms
Agranulocytosis
Sepsis
Fever
Cell Count
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Oncology

Cite this

Cryopreserved autologous marrow infusion following high dose cancer chemotherapy. / Tobias, Jeffrey S.; Weiner, Roy S.; Griffiths, C. Thomas; Richman, Carol M; Parker, Leroy M.; Yankee, Ronald A.

In: European Journal of Cancer (1965), Vol. 13, No. 3, 1977, p. 269-277.

Research output: Contribution to journalArticle

Tobias, Jeffrey S. ; Weiner, Roy S. ; Griffiths, C. Thomas ; Richman, Carol M ; Parker, Leroy M. ; Yankee, Ronald A. / Cryopreserved autologous marrow infusion following high dose cancer chemotherapy. In: European Journal of Cancer (1965). 1977 ; Vol. 13, No. 3. pp. 269-277.
@article{4941df899eb443619a9af722a9890237,
title = "Cryopreserved autologous marrow infusion following high dose cancer chemotherapy",
abstract = "Seventeen patients with advanced malignancies received escalating doses of chemotherapy with adriamycin and cyclophosphamide. Sixty-five per cent of the courses produced circulating granulocyte counts of 500 cells/mm3 or less. Febrile episodes occurred in only 15{\%} of courses and were seen only with doses of chemotherapy that produced granulocyte nadirs of less than 200 cells/mm3. There were no episodes of septicaemia. Ten of the 17 patients received an intensive dose followed by reinfusion of cryopreserved, autologous bone marrow. In 5 of these patients, recovery to 500 granulocytes/mm3 was more rapid following the intensive, marrow-supported course by comparison with the prior, less intensive, unsupported course. We conclude that higher doses of adriamycin and cyclophosphamide than are conventionally used can be given without serious toxicity. Autologous bone marrow reinfusion may have a role in reducing the period of drug-induced granulocytopenia, but effective storage and recovery of human bone marrow remains a major problem.",
author = "Tobias, {Jeffrey S.} and Weiner, {Roy S.} and Griffiths, {C. Thomas} and Richman, {Carol M} and Parker, {Leroy M.} and Yankee, {Ronald A.}",
year = "1977",
doi = "10.1016/0014-2964(77)90215-8",
language = "English (US)",
volume = "13",
pages = "269--277",
journal = "European journal of cancer",
issn = "0014-2964",
publisher = "Pergamon Press Ltd.",
number = "3",

}

TY - JOUR

T1 - Cryopreserved autologous marrow infusion following high dose cancer chemotherapy

AU - Tobias, Jeffrey S.

AU - Weiner, Roy S.

AU - Griffiths, C. Thomas

AU - Richman, Carol M

AU - Parker, Leroy M.

AU - Yankee, Ronald A.

PY - 1977

Y1 - 1977

N2 - Seventeen patients with advanced malignancies received escalating doses of chemotherapy with adriamycin and cyclophosphamide. Sixty-five per cent of the courses produced circulating granulocyte counts of 500 cells/mm3 or less. Febrile episodes occurred in only 15% of courses and were seen only with doses of chemotherapy that produced granulocyte nadirs of less than 200 cells/mm3. There were no episodes of septicaemia. Ten of the 17 patients received an intensive dose followed by reinfusion of cryopreserved, autologous bone marrow. In 5 of these patients, recovery to 500 granulocytes/mm3 was more rapid following the intensive, marrow-supported course by comparison with the prior, less intensive, unsupported course. We conclude that higher doses of adriamycin and cyclophosphamide than are conventionally used can be given without serious toxicity. Autologous bone marrow reinfusion may have a role in reducing the period of drug-induced granulocytopenia, but effective storage and recovery of human bone marrow remains a major problem.

AB - Seventeen patients with advanced malignancies received escalating doses of chemotherapy with adriamycin and cyclophosphamide. Sixty-five per cent of the courses produced circulating granulocyte counts of 500 cells/mm3 or less. Febrile episodes occurred in only 15% of courses and were seen only with doses of chemotherapy that produced granulocyte nadirs of less than 200 cells/mm3. There were no episodes of septicaemia. Ten of the 17 patients received an intensive dose followed by reinfusion of cryopreserved, autologous bone marrow. In 5 of these patients, recovery to 500 granulocytes/mm3 was more rapid following the intensive, marrow-supported course by comparison with the prior, less intensive, unsupported course. We conclude that higher doses of adriamycin and cyclophosphamide than are conventionally used can be given without serious toxicity. Autologous bone marrow reinfusion may have a role in reducing the period of drug-induced granulocytopenia, but effective storage and recovery of human bone marrow remains a major problem.

UR - http://www.scopus.com/inward/record.url?scp=0017349202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017349202&partnerID=8YFLogxK

U2 - 10.1016/0014-2964(77)90215-8

DO - 10.1016/0014-2964(77)90215-8

M3 - Article

C2 - 324770

AN - SCOPUS:0017349202

VL - 13

SP - 269

EP - 277

JO - European journal of cancer

JF - European journal of cancer

SN - 0014-2964

IS - 3

ER -